KAI Pharmaceuticals Director of Business Development Salaries in Boulder
The average KAI Pharmaceuticals Director of Business Development in Boulder earns an estimated $211,438 annually, which includes an estimated base salary of $161,691 with a $49,747 bonus. KAI Pharmaceuticals' Director of Business Development compensation is $45,136 more than the US average for a Director of Business Development. Director of Business Development salaries at KAI Pharmaceuticals in Boulder can range from $73,000 - $390,000.
In Boulder, The Business Development Department at KAI Pharmaceuticals earns $16,169 more on average than the Customer Support Department.
Last updated 5 years ago.
- $161,691
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at KAI Pharmaceuticals
In Boulder, Directors of Business Development earn $3,462 more than Directors of Business Development.
Compensation at KAI Pharmaceuticals by Department
In Boulder, The Business Development Department averages $16,169 more than the Customer Support Department, and $4,212 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to KAI Pharmaceuticals reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to KAI Pharmaceuticals reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at KAI Pharmaceuticals Rate Their Compensation
The majority of Directors of Business Development at KAI Pharmaceuticals believe they're compensated fairly. 100% of Directors of Business Development at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals
